PharmaTher Holdings Ltd. (OTCMKTS:PHRRF – Get Free Report) shares crossed below its fifty day moving average during trading on Tuesday. The stock has a fifty day moving average of $0.04 and traded as low as $0.0350. PharmaTher shares last traded at $0.0370, with a volume of 695,584 shares trading hands.
PharmaTher Stock Performance
The business has a 50 day moving average of $0.04 and a 200-day moving average of $0.05.
PharmaTher Company Profile
PharmaTher Holdings Ltd. is a specialty pharmaceutical company focused on developing ketamine- and psychedelic-based medicines. Its research targets potential uses in mental health, neurological disorders and pain, with ketamine as a central area of development. The company has pursued pharmaceutical formulations and delivery approaches for ketamine, as well as clinical development of ketamine for conditions including Parkinson’s disease. These programs are investigational; the company’s development work does not mean its products are approved treatments for those conditions.
Read More
- Five stocks we like better than PharmaTher
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Receive News & Ratings for PharmaTher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaTher and related companies with MarketBeat.com's FREE daily email newsletter.
